Press Releases
Press Releases
-
July 30, 2020
Gilead Sciences Announces Third Quarter 2020 Dividend -
July 30, 2020
Gilead Sciences Announces Second Quarter and First Half 2020 Financial Results -
July 28, 2020
Gilead Sciences and Satcher Health Leadership Institute at Morehouse School of Medicine Partner to Study Racial Health Inequities Associated with COVID-19 -
July 24, 2020
U.S. FDA Approves Kite’s Tecartus™, the First and Only CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma -
July 24, 2020
Gilead and Galapagos Announce Positive European CHMP Opinion for Jyseleca® (Filgotinib) for the Treatment of Adults With Moderate to Severe Rheumatoid Arthritis -
July 21, 2020
Gilead Sciences Secures Exclusive Option to Acquire Tizona Therapeutics for $300 Million -
July 16, 2020
Gilead Sciences to Release Second Quarter 2020 Financial Results on Thursday, July 30, 2020 -
July 13, 2020
Gilead Sciences and Arcus Biosciences Complete Closing of Their 10-Year Partnership to Co-Develop and Co-Commercialize Next-Generation Cancer Immunotherapies -
July 10, 2020
Gilead Presents Additional Data on Investigational Antiviral Remdesivir for the Treatment of COVID-19 -
July 8, 2020
Gilead Sciences Presents Survey Findings on PrEP Access and Utilization in the U.S. During COVID-19 Shelter-in-Place Orders